Novartis‘ pharmaceutical sales increased by 7.1 per cent to Rs 112.62 crore from Rs 105.19 crore in the similar period of last year. However, its generic sales declined to Rs 10.79 crore from Rs 18.71 crore and that of OTC division .World Pharma News – The US Food and Drug Administration (FDA) has .
Results from the ARTEN trial presented at the 5th International AIDS Society (IAS) conference in Cape Town, South Africa demonstrated non-inferiority regarding efficacy between Viramune® (nevirapine) and ritonavir boosted atazanavir (atazanavir/r) both combined with tenofovir and emtricitabine (Truvada ®). novartis pharmaceutical
Amgen Inc. (Nasdaq: AMGN) announced the U.S. Food and Drug Administration (FDA) has approved revisions to the U.S. prescribing information for the epidermal growth factor receptor (EGFr) class of antibodies, including Vectibix(R) (panitumumab). novartis pharmaceutical
